AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

Abstract

AMPK has context-dependent effects in cancer, cautioning against the widespread use of an AMPK activator across disease settings. The development of therapeutics targeting fat metabolism is warranted in ER⁺ breast cancer.